The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of Ra-223 combined with hormonal therapy and denosumab for treatment of hormone receptor-positive breast cancer with bone-dominant metastasis.
 
Naoto T. Ueno
Honoraria - Kyowa Hakko Kirin
Research Funding - Amgen; Bayer; Bio-Path Holdings; Celgene; Daiichi Sankyo; GlaxoSmithKline; Kyowa Hakko Kirin; Medivation; Merck; Novartis; Puma Biotechnology
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
 
Rie K. Tahara
No Relationships to Disclose
 
Babita Saigal
No Relationships to Disclose
 
Takeo Fujii
No Relationships to Disclose
 
James M. Reuben
No Relationships to Disclose
 
Hui Gao
No Relationships to Disclose
 
Anthony Lucci
Speakers' Bureau - Genomic Health
 
Nuhad K. Ibrahim
Honoraria - Celgene; Novartis; Roche
Speakers' Bureau - Celgene; Novartis; Roche
Research Funding - Archer (Inst); GenomeDx (Inst); Newlink Genetics (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Senthil Damodaran
No Relationships to Disclose
 
Yu Shen
No Relationships to Disclose
 
Diane D. Liu
No Relationships to Disclose
 
Gabriel N. Hortobagyi
Consulting or Advisory Role - Agendia; Bayer; Lilly; Merck; Novartis; Peregrine Pharmaceuticals; Roche
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Debu Tripathy
Consulting or Advisory Role - Nektar; Novartis; Pfizer; Puma Biotechnology
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Bora Lim
No Relationships to Disclose
 
Beth A. Chasen
No Relationships to Disclose